Contracts & Grants

Information is courtesy of the Office of Sponsored Projects. Each listing includes the faculty member's name and school(s) appointments at The University of Texas Health Science Center at Houston, contracting or granting agency, funding amount and project title.

New

Jason L. Anthony, Medical School (MS), Texas Education Agency, $50,000, Texas Pre-Kindergarten Limited English Proficiency Program.

Brian R. Davis, Administration and Finance (A&F), US Immunodeficiency Network (USIDNET), $254,801, Nuclease Facilitated Gene Editing for Primary Immunodeficiency Diseases.

Myriam Fornage, A&F and Graduate School of Biomedical Sciences (GSBS), National Institutes of Health (NIH), $2,854,091, Genes of the CYP450-derived Eicosanoids Pathway in Subclinical Atherosclerosis.

Carin A. Hagberg, MS, Patient Transfer Systems, Inc., $45,090, An Evaluation of the Rapid Airway Management Positioner (RAMP) in Morbidly Obese Patients.

Lenard M. Lichtenberger, MS and GSBS, PLX Pharma Inc., $589,405, GI Safety and Therapeutics of Oil-Based PC-NSAIDS.

Mohammad Madjid, A&F, POM Wonderful, LLC, $123,500, Effect of Pomegranate Purified Polyphenol Extract on Influenza Virus.

Maureen D. Mayes, MS, Fred Hutchinson Cancer Research Center, $25,825, Nonmyeloablative Hematopoietic Cell Transplantation for Severe Systemic Sclerosis.

Donald A. Molony, MS, University of New Mexico, $31,561, Navajo Uranium Assessment and Kidney Health Project.

Luis Ostrosky-Zeichner, MS, Astellas Pharma US, Inc., $41,964, Integration of the Micafungin Antifungal Susceptibility Data: In Vitro Susceptibility Breakpoint Exploration.

James T. Willerson, A&F, Texas Heart Institute, $36,766, Cardiovascular Cell Therapy Research Network.

Xiaodong Zhou, MS, Department of Defense, $928,125, The Integrative Studies of Genetic and Environmental Factors in SSC.

Renewal

Michael R. Blackburn, MS and GSBS, NIH, $1,470,450, Adenosine Signaling and Lung Fibrosis.

Phillip B. Carpenter, MS and GSBS, Robert A. Welch Foundation, $150,000, How Methylation Influences the DNA Damage Response.

John W. Crommett, MS, Christopher Reeves Paralysis Foundation, $149,600, North American Clinical Trials Network for the Treatment of Spinal Cord Injury.

Ralph F. Frankowski, School of Public Health (SPH), Christopher Reeves Paralysis Foundation, $360,388, North American Registry Network for Spinal Cord Injury.

F. Gerard Moeller, MS and GSBS, NIH, $588,060, Serotonin, Impulsivity, and Substance Abuse.

Blanca I. Restrepo, SPH and GSBS, Texas Department of State Health Services, $12,496, Tuberculosis Elimination.

Previous story Next story